68 related articles for article (PubMed ID: 38542466)
21. Role of Vitamin C in Selected Malignant Neoplasms in Women.
Markowska A; Antoszczak M; Markowska J; Huczyński A
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215535
[TBL] [Abstract][Full Text] [Related]
22. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
23. Vitamin K: A novel cancer chemosensitizer.
Gul S; Maqbool MF; Maryam A; Khan M; Shakir HA; Irfan M; Ara C; Li Y; Ma T
Biotechnol Appl Biochem; 2022 Dec; 69(6):2641-2657. PubMed ID: 34993998
[TBL] [Abstract][Full Text] [Related]
24. Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma.
Yang Y; Li G; Lu Z; Liu Y; Kong J; Liu J
Front Oncol; 2021; 11():726213. PubMed ID: 34900676
[TBL] [Abstract][Full Text] [Related]
25. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance.
Palamaris K; Felekouras E; Sakellariou S
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771695
[TBL] [Abstract][Full Text] [Related]
26. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review.
Yang J; Xu R; Wang C; Qiu J; Ren B; You L
Cancer Commun (Lond); 2021 Dec; 41(12):1257-1274. PubMed ID: 34331845
[TBL] [Abstract][Full Text] [Related]
27. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma.
Hu X; Chen W
World J Clin Cases; 2021 Jul; 9(19):4998-5006. PubMed ID: 34307550
[TBL] [Abstract][Full Text] [Related]
28. PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
Tartaglione S; Mancini P; Viggiani V; Chirletti P; Angeloni A; Anastasi E
PLoS One; 2021; 16(5):e0251656. PubMed ID: 34015010
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting survival in operated pancreatic cancer: Does tumor localization have a significant effect on treatment outcomes?
Sakin A; Sahin S; Sakin A; Atci MM; Arici S; Yasar N; Demir C; Geredeli C; Cihan S
North Clin Istanb; 2020; 7(5):487-493. PubMed ID: 33163885
[TBL] [Abstract][Full Text] [Related]
30. Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer.
Huang J; Lok V; Ngai CH; Zhang L; Yuan J; Lao XQ; Ng K; Chong C; Zheng ZJ; Wong MCS
Gastroenterology; 2021 Feb; 160(3):744-754. PubMed ID: 33058868
[TBL] [Abstract][Full Text] [Related]
31. BFRF1 protein is involved in EBV-mediated autophagy manipulation.
Gonnella R; Dimarco M; Farina GA; Santarelli R; Valia S; Faggioni A; Angeloni A; Cirone M; Farina A
Microbes Infect; 2020; 22(10):585-591. PubMed ID: 32882412
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma.
Matsumura K; Hayashi H; Uemura N; Zhao L; Higashi T; Yamao T; Kitamura F; Nakao Y; Yusa T; Itoyama R; Imai K; Yamashita YI; Baba H
In Vivo; 2020; 34(5):2845-2850. PubMed ID: 32871823
[TBL] [Abstract][Full Text] [Related]
33. Epithelial-Mesenchymal Transition in Cancer: A Historical Overview.
Ribatti D; Tamma R; Annese T
Transl Oncol; 2020 Jun; 13(6):100773. PubMed ID: 32334405
[TBL] [Abstract][Full Text] [Related]
34. Early detection of pancreatic cancer.
Pereira SP; Oldfield L; Ney A; Hart PA; Keane MG; Pandol SJ; Li D; Greenhalf W; Jeon CY; Koay EJ; Almario CV; Halloran C; Lennon AM; Costello E
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):698-710. PubMed ID: 32135127
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of pancreatic cancer: paving the way to better anticancer strategies.
Qin C; Yang G; Yang J; Ren B; Wang H; Chen G; Zhao F; You L; Wang W; Zhao Y
Mol Cancer; 2020 Mar; 19(1):50. PubMed ID: 32122374
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy.
Sarantis P; Koustas E; Papadimitropoulou A; Papavassiliou AG; Karamouzis MV
World J Gastrointest Oncol; 2020 Feb; 12(2):173-181. PubMed ID: 32104548
[TBL] [Abstract][Full Text] [Related]
37. Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study.
Tartaglione S; Pecorella I; Zarrillo SR; Granato T; Viggiani V; Manganaro L; Marchese C; Angeloni A; Anastasi E
Biochem Med (Zagreb); 2019 Jun; 29(2):020707. PubMed ID: 31223261
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.
Rawla P; Sunkara T; Gaduputi V
World J Oncol; 2019 Feb; 10(1):10-27. PubMed ID: 30834048
[TBL] [Abstract][Full Text] [Related]
39. EMT Transition States during Tumor Progression and Metastasis.
Pastushenko I; Blanpain C
Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
[TBL] [Abstract][Full Text] [Related]
40. Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer.
Li W; Liu H; Qian W; Cheng L; Yan B; Han L; Xu Q; Ma Q; Ma J
Comput Struct Biotechnol J; 2018; 16():479-487. PubMed ID: 30455857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
